Combination therapy should only be reviewed by a licensed provider because dosing, monitoring, and safety risks become more complex
Yun SJ, Kwon OS, Han JH, et al
Among large employers with 200 or more workers, only 19% covered GLP-1 drugs for weight loss in their largest plan in 2025, rising to 43% at firms with 5,000 or more workers, according to the KFF 2025 Employer Health Benefits Survey
In this case, Theophyline inhibits Phosphodietrase
Recognising the signs is important, and one symptom may present itself when you go to the toilet
Pathophysiology of IrAEs Several immunopathogenic mechanisms (i.e., cellular autoimmunity, autoantibodies, complement activation, cytokines/chemokines release, genetics and alterations of the gut microbiome) have been suggested to be involved in the development of ICI-related irAEs ( Figure 2 )